[논문]인간 A549 폐암세포에서 비스테로이드성 항염증제와 genistein의 복합처리에 의한 NAG-1 의존적 세포사멸 증진 효과

김초희; 김민영; 이수연; 문지영; 한송이; 박혜경; 강호성

doi:10.5352/jls.2009.19.8.1073

인간 A549 폐암세포에서 비스테로이드성 항염증제와 genistein의 복합처리에 의한 NAG-1 의존적 세포사멸 증진 효과
Combined Treatment of Nonsteroidal Anti-inflammatory Drugs and Genistein Synergistically Induces Apoptosis via Induction of NAG-1 in Human Lung Adenocarcinoma A549 Cells 원문보기

생명과학회지 = Journal of life science, v.19 no.8 = no.112, 2009년, pp.1073 - 1080

김초희 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 김민영 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 이수연 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 문지영 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소) , 한송이 (조선대학교 의과대학 내성세포연구센터) , 박혜경 (한국나노바이오테크놀러지센터) , 강호성 (부산대학교 자연과학대학 분자생물학과, 유전공학연구소)

초록
AI-Helper

비스테로이드성 항염증약(nonsteroidal anti-inflammatory drugs; NSAIDs)은 항염 및 진통효과를 나타내며, 염증억제 외에 다양한 신호전달 분자를 통해 여러 가지 세포생리활성을 조절하며, 암세포에서는 세포사멸 유도를 통한 항암제 효과를 보이고 있다. 본 연구에서는 NSAIDs가 암세포사멸프로그램을 작동시키는데 있어 phosphatidyl inositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) 그리고 MEK1/2-ERK1/2 신호 전달계과 같은 anti-apoptotic program이 NSAIDs의 효과를 경감시키는 것으로 예상하고, 이들 항세포사멸 프로그램을 억제하였을 경우, NSAIDs의 세포사멸 유도작용이 증가되는지 그 가능성을 조사하였다. 세포사멸은 Hoeschst 33342으로 핵응축과 핵 쪼개짐을 염색하여 확인하였다. Western blotting을 통해 단백질 발현과 역전사중합효소연쇄반응을 통해 mRNA 발현을 확인하였다. NSAIDs 처리와 동시에 PI3K-Akt/PKB와 MEK-ERK1/2 신호전달계의 억제제를 함께 처리했을 때, NSAIDs의 세포사멸유도작용이 증가함을 확인하였다. 또한 PI3K와 MEKl/2 신호전달계의 상위에 존재하는 receptor tyrosine kinases (RTKs)의 억제제인 genistein을 함께 처리하였을 때에도 유사한 효과가 나타남을 확인하였다. 그리고 이들 복합처리에 의해 NAG-1 발현이 증가하며 NAG-1 interference 하였을 경우 복합처리에 의한 세포사멸증진 효과가 사라짐을 확인하였다. 본 연구결과는 암세포에 활성화 되어 있는 세포생존프로그램을 제어하는 물질(genistein 혹은 LY294002+U0126)을 복합처방함으로써 NSAIDs의 항암작용을 증진시킬 수 있음을 보여준다.

Abstract ▼ AI-Helper

A number of studies have demonstrated that the regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the risks of colorectal, oesophageal and lung cancers. NSAIDs have been shown to exert their anti-cancer effects through inducing apoptosis in cancer cells. The susceptibility of tumor cells to anti-tumor drug-induced apoptosis appears to depend on the balance between pro-apoptotic and anti-apoptotic programs such as nuclear factor kB (NF-kB), phosphatidylinositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) and MEK1/2-ERK1/2 pathways. We examined the effects of pro-survival PI3K and ERK1/2 signal pathways on cell cycle arrest and apoptosis in response to NSAIDs including sulindac sulfide and NS398. We show that simultaneous inhibition of the Akt/PKB and ERK1/2 signal cascades could synergistically enhance the potential pro-apoptotic activities of sulindac sulfide and NS398. Similar enhancement was observed in cells treated with sulindac sulfide or NS398 and 100 ${\mu}$M genistein, an inhibitor of receptor tyrosine kinases (RTKs) that are upstream of PI3K and MEK1/2 signaling. We further demonstrate that NAG-1 is induced and plays a critical role(s) in apoptosis by NSAIDs-based combined treatment. In sum, our results show that combinatorialtreatment of sulindac sulfide or NS398 and genistein results in a highlysynergistic induction of apoptotic cell death to increase the chemopreventive effects of the NSAIDs, sulindac sulfide and NS398.

주제어

참고문헌 (39)

Adhami, V. M., A. Malik, N. Zaman, S. Sarfaraz, I. A. Siddiqui, D. N. Syed, F. Afaq, F. S. Pasha, M. Saleem, and H. Mukhtar. 2007. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 13, 1611-1619

상세보기
Baek, S. J., K. Kim, J. B. Nixon, L. C. Wilson, and T. E. Eling. 2001. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901-908

상세보기
Baek, S. J., R. Okazaki, S. H. Lee, J. Martinez, J. S. Kim, K. Yamaguchi, Y. Mishina, D. W. Martin, A. Shoieb, M. F. McEntee, and T. E. Eling. 2006. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131, 1553-1560

상세보기
Baek, S. J., L. Wilson, and T. E. Eling. 2002. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-434

상세보기
Banu, N., A. Buda, S. Chell, D. Elder, M. Moorghen, C. Paraskeva, D. Qualtrough, and M. Pignatelli. 2007. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor

상세보기
Brognard, J., A. S. Clark, Y. Ni, and P. A. Dennis. 2001. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61, 3986-3997

상세보기
Brognard, J. and P. A. Dennis. 2002. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ. 9, 893-904

상세보기
Chen, Y. L., P. C. Lin, S. P. Chen, C. C. Lin, N. M. Tsai, Y. L. Cheng, W. L. Chang, S. Z. Lin, and H. J. Harn. 2007. Activation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 via Extracellular Signal-Regulated

상세보기
Clark, A. S., K. West, S. Streicher, and P. A. Dennis. 2002. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707-717

상세보기
Crowell, J. A. and V. E. Steele. 2003. AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment. J. Natl. Cancer Inst. 95, 291-302

상세보기
Crowell, J. A., V. E. Steele, and J. R. Fay. 2007. Targeting the AKT protein kinase for cancer chemoprevention. Mol. Cancer Ther. 6, 2139-2948

상세보기
Danial, N. N. and S. J. Korsmeyer. 2004. Cell death: Critical control points. Cell 116, 205-219

상세보기
Dixon, R. A. and D. Ferreira. 2003. Genistein. Phytochemistry 60, 205-211
Garg, A. K., T. A. Buchholz, and B. B. Aggarwal. 2005. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 7, 1630-1647

상세보기
Hawk, E. T. and B. Levin. 2005. Colorectal cancer prevention. J. Clin. Oncol. 23, 378-391

상세보기
Hu, H., C. Jiang, G. Li, and J. Lu. 2005. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 269, 1374-1381

상세보기
Huang, C., J. Li, M. Ding, S. S. Leonard, L. Wang, V. Castranova, V. Vallyathan, and X. Shi. 2001. UV Induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal Cl 41 cells through hydrogen peroxide. J. Biol. Chem. 276, 40234-40240

상세보기
Huang, Y., Q. He, M. J. Hillman, R. Rong, and M. S. Sheikh. 2001. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res. 61, 6918-6924

상세보기
Hung, W. C., H. C. Chang, M. R. Pan, T. H. Lee, and L. Y. Chuang. 2000. Induction of p27KIP1 as a Mechanism Underlying NS398- Induced Growth Inhibition in Human Lung Cancer Cells. Mol. Pharmacol. 58, 1398-1403

상세보기
Kim, C. H., S. I. Han, S. Y. Lee, H. S. Youk, J. Y. Moon, H. Q. Duong, M. J. Park, Y. M. Joo, H. G. Park, Y. J. Kim, M. A. Yoo, S. C. Lim, and H. S. Kang. 2007. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J. Cell Phyiol. 211, 371-385

상세보기
Li, M., X. Wu, and X. C. Xu. 2001. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin. Cancer Res. 7, 1010-1016

상세보기
Liou, J. Y., D. Ghelani, S. Yeh, and K. K. Wu. 2007. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon. Cancer Res. 67, 3185-3191

상세보기
Liu, X. H., S. Yao, A. Kirschenbaum, and A. C. Levine. 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58, 4245-4249

상세보기
Lowe, S. W. and A. W. Lin. 2000. Apoptosis in cancer. Carcinogenesis 21, 485-495

상세보기
MacKeigan, J. P., D. Taxman, D. Hunter, H. S. Earp 3rd, L. M. Graves, and J. P. Ting. 2002. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin. Cancer Res. 8, 2091-2099

상세보기
Meeran, S. M. and S. K. Katiyar. 2008. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 13, 2191-2202

상세보기
Meier, F., S. Busch, K. Lasithiotakis, D. Kulms, C. Garbe, E. Maczey, M. Herlyn, and B. Schittek. 2007. Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br. J. Dermatol. 156,

상세보기
Minter, H. A., J. W. Eveson, S. Huntley, D. J. Elder, and A. Hague. 2003. The Cyclooxygenase 2-selective Inhibitor NS398 Inhibits Proliferation of Oral Carcinoma Cell Lines by Mechanisms Dependent and Independent of Reduced Prostaglandin E2 Synthesis. Clin. Cancer Res. 9, 1885-1897

상세보기
Newman, D., M. Sakaue, J. S. Koo, K. S. Kim, S. J. Baek, T. E. Eling, and A. M. Jetten. 2003. Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma

상세보기
Saha, D., H. Pyo, and H. Choy. 2003. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer. Am. J. Clin. Oncol. 26, S70-74
Tegeder, I., J. Pfeilschifter, and G. Geisslinger. 2001. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15, 2057-2072

상세보기
Totzke, G., K. Schulze-Osthoff, and R. U. Janicke. 2003. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22, 8021-8030

상세보기
Ulrich, C. M., J. Bigler, and J. D. Potter. 2006. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat. Rev. Cancer 6, 130-140

상세보기
Vane, J. R. and R. M. Botting. 1998. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am. J. Med. 104, 2S-8S
Wilson, L. C., S. J. Baek, A. Call, and T. E. Eling. 2003. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105, 747-753

상세보기
Yamaguchi, H. and H. G. Wang. 2001. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 53, 7779-7786
Yamaguchi, K., S. H. Lee, T. E. Eling, and S. J. Baek. 2004. Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of posphatidylinositol 3-knase/AKT/GSK-3 Pathway. J. Biol. Chem. 279, 49617-49623

상세보기
Yeh, T. C., P. C. Chiang, T. K. Li, J. L. Hsu, C. J. Lin, S. W. Wang, C. Y. Peng, and J. H. Guh. 2007. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochm. Pharmacol. 73, 782-792

상세보기
Zhang, L., J. Yu, B. H. Park, K. W. Kinzler, and B. Vogelstein. 2000. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992

상세보기

저자의 다른 논문 :

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format